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Abstract Rat (r) OCT2 was identified as the second member of
the organic cation transporter (OCT) family, and is predomi-
nantly expressed in the kidney. We reported previously that
rOCT2 was responsible for the gender differences in renal
basolateral membrane organic cation transport activity. As renal
rOCT2 expression in males is much higher than that in females,
we hypothesized that rOCT2 expression may be under the
control of sex hormones. Treatment of male and female rats with
testosterone significantly increased the expression levels of
rOCT2 mRNA and protein in the kidney, whereas estradiol
treatment moderately decreased the expression levels of rOCT2.
There was no regulation of renal rOCT1 mRNA expression by
testosterone or estradiol. Treatment of male and female rats with
testosterone significantly stimulated the tetraethylammonium
(TEA) accumulation by renal slices, whereas estradiol treatment
caused a decrease in the TEA accumulation by slices from male
but not female rats. The present findings suggested that
testosterone up-regulates renal rOCT2 expression and estradiol
moderately down-regulates rOCT2.
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1. Introduction
Secretion of drugs and xenobiotics is an important physio-
logical function of the renal proximal tubules. In the kidney,
organic cation secretion is a two-step process with carrier-
mediated steps at both basolateral and brush-border mem-
branes [1^3]. These processes have been functionally charac-
terized by uptake measurements using isolated renal mem-
brane vesicles [4^8] and cultured renal epithelial cells [9,10].
Renal tubular secretion of cationic substances is performed by
two distinct classes of organic cation transporters (OCT): one
facilitated by the transmembrane potential di¡erence in the
basolateral membranes and the other driven by the transmem-
brane H gradient in the brush-border membranes. In recent
years, several members of a common gene family of organic
cation transporters have been cloned and characterized [11].
The ¢rst organic cation transporter, rOCT1, was cloned from
rat kidney [12]. We identi¢ed a rat organic cation transporter,
rOCT2, the second member of the OCT family [13]. rOCT2
shows 67% amino acid identity with rOCT1 and is expressed
predominantly in the kidney. Functional studies using Xeno-
pus oocytes [13^15] and transfectants of mammalian kidney
cells [16^18] suggested that both rOCT1 and rOCT2 are multi-
speci¢c facilitative transporters that recognize a variety of
cations with di¡erent molecular structures, tetraethylammoni-
um (TEA), 1-methyl-4-phenylpiridinium, N1-methylnicotin-
amide, choline and dopamine, and are potential-sensitive or-
ganic cation transporters.
Bowman and Hook [19] reported that the uptake of p-ami-
nohippurate and TEA by renal cortical slices from male rats
was greater than that by those of female rats, suggesting gen-
der di¡erences in the basolateral membrane transport capaci-
ties for both organic anions and cations. We examined
whether rOCT1 and/or rOCT2 contribute to the gender di¡er-
ences in organic cation transport activity in the rat kidney
[20]. We observed that the expression levels of rOCT2
mRNA and protein in the kidney of males were much higher
than those of females, and there were no gender di¡erences in
mRNA expression of rOCT1. These observations suggested
that rOCT2 is responsible for the gender di¡erences in renal
basolateral membrane organic cation transport activity. On
the other hand, renal organic anion transporting polypeptide
(oatp) mRNA levels are higher in males than in females. Fur-
thermore, renal oatp expression is under the control of andro-
gen, and to a lesser extent estrogen [21]. We hypothesized that
rOCT2 expression may be under the control of sex hormones.
This study was performed to examine whether gender-de-
pendent di¡erences in rOCT2 expression are due to sex hor-
mones. We report here that rOCT2 expression is regulated by
testosterone, and moderately by estradiol.
2. Materials and methods
2.1. Materials
[1-14C]TEA bromide (185.0 MBq/mmol) was obtained from Du
Pont-New England Nuclear Research Products (Boston, MA, USA).
HEPES (N-2-hydroxyethylpiperazine-NP-2-ethanesulfonic acid) was
purchased from Nacalai Tesque (Kyoto, Japan). Testosterone and
17L-estradiol were obtained from Nacalai Tesque (Kyoto, Japan).
All other chemicals were of the highest purity available.
2.2. Treatment of rats with testosterone and estradiol
Testosterone (10 mg/0.1 ml of olive oil) or 17L-estradiol (1 mg/
0.1 ml of olive oil) was administered subcutaneously in the nape of
the neck to male and female rats once daily for 7 days. The control
rats were given the same volume of olive oil. After administration,
rats were killed and kidneys were excised for isolation of RNA and
crude plasma membranes. When rats were killed, blood was taken for
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measurement of serum levels of testosterone and 17L-estradiol. Serum
testosterone and 17L-estradiol were assayed with the Enzyme Immu-
noassay Kit (Cayman Chemical Co., MI, USA). The animal experi-
ments were performed in accordance with The Guideline for Animal
Experiments of Kyoto University.
2.3. Northern blot hybridization
Total RNA was extracted from the whole kidney using the guani-
dine isothiocyanate method [22]. Brie£y, 10 Wg of total RNA was
electrophoresed in 1% denaturing agarose gel containing formalde-
hyde and transferred onto nylon membranes. The quality of RNA
was assessed by ethidium bromide staining. After transfer, blots
were hybridized at high stringency (50% formamide, 5USSPE
[1USSPE = 0.15 M NaCl, 10 mM NaH2PO4, and 1 mM EDTA],
5UDenhardt’s solution, 0.2% SDS, 10 Wg/ml salmon sperm DNA at
42‡C) with cDNA encoding rOCT1, rOCT2 or rat glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) labeled with [K-32P]dCTP. The
cDNA probes corresponded to nucleotide positions 399^1882
(rOCT1), 362^2114 (rOCT2) and 10^1047 (GAPDH) of the published
sequences in the GenBank/EBI Data Bank. After hybridization, the
blots were washed twice in 2USSC (1USSC = 0.15 M NaCl, 15 mM
sodium citrate, pH 7.0)/0.5% SDS at room temperature for 10 min,
and then twice in 0.2USSC/0.5% SDS at 65‡C for 30 min. Dried
membranes were exposed to the imaging plates of Fujix BIO-Imaging
Analyzer BAS 2000 II (Fuji Photo Film).
2.4. Immunoblotting
The crude plasma membrane fraction of rat kidney was prepared as
described [23]. The membrane fraction (50 Wg) was separated by 10%
sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and analyzed by immunoblotting with anti-rOCT2 antiserum
as described [20]. The blots were incubated with antiserum preab-
sorbed with the synthetic antigen peptide (1 Wg/ml) or antiserum
(1:1000) overnight at 4‡C. The blots were washed, and the bound
antibody was detected on X-ray ¢lm by enhanced chemiluminescence
(ECL) with a horseradish peroxidase-conjugated anti-rabbit IgG anti-
body and cyclic diacylhydrazides (Amersham).
2.5. Uptake study by kidney slices
Slices of kidneys including renal cortex and outer medulla from
male and female Wistar rats (9 weeks old, 180^260 g body weight)
were put in ice-cold oxygenated incubation bu¡er comprised of
120 mM NaCl, 16.2 mM KCl, 1 mM CaCl2, 1.2 mM MgSO4 and
10 mM NaH2PO4/Na2HPO4, pH 7.5. Uptake study by kidney slices
was performed as described previously [24]. Slices weighing 40^90 mg
were randomly selected and placed for incubation in a £ask contain-
ing 3 ml of incubation bu¡er with [14C]TEA (50 WM, 0.89 kBq/ml).
The uptake of [14C]TEA was carried out at 25‡C under an atmosphere
of 100% oxygen. D-[3H]Mannitol (50 or 5 WM, 3.7 kBq/ml) was used
to estimate the extracellular trapping and non-speci¢c uptake of
[14C]TEA. After incubation for an appropriate time, each slice was
rapidly removed from the £ask, washed twice in 3 ml of ice-cold
incubation medium, blotted on ¢lter paper, weighed and solubilized
in 0.5 ml of NCS II (Amersham International, Buckinghamshire,
UK). The radioactivity was determined in 5 ml of ACS II (Amer-
sham) by liquid scintillation counting.
2.6. Statistical analysis
Statistical analysis was performed by Student’s t-test, or by one-way
analysis of variance followed by Fisher’s t-test, when multiple com-
parisons against the control were needed.
3. Results
As shown in Table 1, the serum level of testosterone in
intact male rats was six-fold higher than that in females. In
contrast, the serum level of estradiol in intact female rats was
four-fold higher than that in males. To determine whether the
gender di¡erences in rOCT2 expression were produced by
these hormones, male and female rats were subcutaneously
administered either testosterone or estradiol for 7 days. After
treatment with either hormone, serum levels of testosterone
and estradiol increased markedly in both male and female rats
(Table 1). Increases in serum testosterone level agreed with
those reported previously [21].
Fig. 1 shows Northern blots of renal rOCT1 and rOCT2
mRNA expression in male and female kidneys after treatment
with the hormones. Administration of testosterone to rats of
both sexes caused signi¢cant increases in rOCT2 mRNA ex-
pression (Fig. 1B). In contrast, administration of estradiol
produced a slight, but not statistically signi¢cant, decrease
in rOCT2 expression in males, but not in females. These hor-
mone treatments had little e¡ect on rOCT1 or GAPDH
mRNA expression (Fig. 1).
To determine whether the up- or down-regulation of
rOCT2 mRNA expression was accompanied by a modulation
of rOCT2 protein expression, immunoblot analysis was per-
formed. Previously, a primary band for rOCT2 with a size of
74 kDa (calculated molecular weight of 66 kDa) was detected
exclusively in the membranes of the kidney [20]. Treatment of
male (Fig. 2A) and female (Fig. 2B) rats with testosterone
produced marked increases in rOCT2 expression. On the oth-
er hand, treatment with estradiol resulted in a slight decrease
in the rOCT2 expression in males, but not in females. Thus,
the modulation of rOCT2 protein expression by hormone
treatment appeared to be due to regulation of its mRNA
expression.
Next, we examined whether the regulation of rOCT2 ex-
pression by administration of testosterone or estradiol pro-
duced alterations in organic cation transport activity. As
shown in Fig. 3, TEA accumulation was higher in slices
from testosterone-treated male (Fig. 3A) and female (Fig.
3B) rat kidneys than in those from control rats given only
the vehicle. In contrast, the accumulation was lower in slices
from estradiol-treated male rats than in those from controls.
Treatment with estradiol had no signi¢cant e¡ect on the TEA
accumulation in slices from female rats.
4. Discussion
This study demonstrated that the expression of rOCT2 in
the kidney is regulated by testosterone, and in part by estra-
Table 1
Serum levels of testosterone and estradiol in male and female rats
Testosterone (ng/ml) Estradiol (ng/ml)
Male Female Male Female
Intact 1.5 þ 0.026 0.25 þ 0.021 0.022 þ 0.0047 0.092 þ 0.013
Control 0.55 þ 0.082 0.74 þ 0.13 0.083 þ 0.028 0.18 þ 0.054
Testosterone 182 þ 47* 138 þ 9.1* 0.54 þ 0.022 0.50 þ 0.13
Estradiol 0.59 þ 0.079 1.6 þ 0.31 5.2 þ 0.94* 8.1 þ 1.3*
Serum concentrations of testosterone and 17L-estradiol in untreated (intact) male and female rats, and rats treated with either testosterone
(10 mg/day) or 17L-estradiol (1 mg/day) for 7 days. Control rats were given vehicle. Each point represents the mean þ S.E.M. of three or four
rats. *P6 0.05, signi¢cantly di¡erent from control.
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diol, modulating the gender di¡erences in organic cation
transport activity of the basolateral membrane of renal tubu-
lar cells. Gender di¡erences in organic cation transport activ-
ities of rat kidney have been described by Bowman and Hook
[19], who demonstrated that accumulation of TEA was great-
er in renal cortical slices from male than female rats. Since
uptake by renal slices is considered to predominantly re£ect
transport across the basolateral membranes, the gender di¡er-
ence in TEA transport could result from di¡erences in the
expression of basolateral membrane transporter(s). In addi-
tion, we recently demonstrated gender-related basolateral
membrane organic cation transport activity using basolateral
membrane vesicles and renal slices from male and female rats
[20].
In our previous study, Northern blot and immunoblot anal-
yses revealed that the levels of both rOCT2 transcript and
protein expression were greater in the kidney of male than
of female rats. In contrast, there were no appreciable gender
di¡erences in the expression level of rOCT1, rOCT3 or
rOAT1 mRNA [20]. Thus, we postulated that rOCT2 could
be an organic cation transporter whose expression is regulated
by gender-related factors, whereas rOCT1 may be a constitu-
tive type of transporter. In this study, this assumption was
tested by treating rats with testosterone and estradiol, since
we detected gender di¡erences in serum levels of these hor-
mones (Table 1). Treatment with testosterone produced a
marked increase in the steady-state level of rOCT2 mRNA
in the male and female rat kidney. We speculated that
rOCT2 mRNA expression was under strong stimulatory reg-
ulation by testosterone. In contrast to the case of rOCT2,
testosterone treatment showed no e¡ect on the expression of
rOCT1 mRNA (Fig. 1). This indicated that rOCT1 could be
an organic cation transporter expressed constitutively in the
kidney with no gender di¡erences. Treatment with estradiol
caused a small decrease in rOCT2 expression in male rats,
suggesting that the expression may be weakly down-regulated
by estradiol. In the female rat kidney, administration of es-
tradiol had no e¡ect on rOCT2 expression (Figs. 1 and 2B).
Although the precise mechanisms underlying this di¡erence in
e¡ect are unknown, the gender-dependent di¡erential regula-
tion of rOCT2 expression by estradiol via other endogenous
factor(s) might be involved.
The present ¢ndings support the linkage between hormonal
regulation of rOCT2 expression and organic cation transport
activity in the kidney. The TEA accumulation by slices from
the male rat kidney was signi¢cantly enhanced by treatment
with testosterone, but was depressed by estradiol treatment
(Fig. 3A). On the other hand, the TEA accumulation by slices
Fig. 1. Northern blot analysis of total RNA of the kidney from
male and female rats treated with testosterone or estradiol. A: Total
RNA (10 Wg) of the kidney from rats treated with vehicle (CONT),
testosterone (TS) or 17L-estradiol (E2) was hybridized with rOCT1,
rOCT2 or GAPDH cDNA probe under high stringency. B: Densi-
tometric quantitation of rOCT1 and rOCT2 mRNA, corrected for
loading using GAPDH. Control levels were set at 100%. No di¡er-
ences were detected in GAPDH among rats. Each column represents
the mean þ S.E.M. of four rats. *P6 0.05, signi¢cantly di¡erent
from control.
Fig. 2. Immunoblot analysis of membrane proteins isolated from
male and female rat kidneys treated with testosterone or estradiol.
50 Wg of crude membranes from male (A) and female (B) rat kid-
neys were separated by SDS^PAGE. rOCT2 was identi¢ed using
polyclonal antibodies as described in Section 2. CONT, rats treated
with vehicle; TS, rats treated with testosterone; E2, rats treated
with 17L-estradiol.
Fig. 3. TEA accumulation by kidney slices from male and female
rats treated with testosterone and estradiol. Kidney slices from
males (A) and females (B) were incubated at 25‡C in bu¡er contain-
ing 50 WM [14C]TEA for 60 min. CONT, rats treated with vehicle;
TS, rats treated with testosterone; E2, rats treated with 17L-estra-
diol. Each column represents the mean þ S.E.M. of three separate
experiments in three slices. *P6 0.05, signi¢cantly di¡erent from
control.
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from the female kidney was also stimulated by testosterone,
but was mostly una¡ected by estradiol (Fig. 3B). Thus, the
up- or down-regulation of rOCT2 expression appeared to be
related to the TEA transport activity in the kidneys. In other
words, rOCT2 should be a primary organic cation transporter
in the basolateral membranes of the renal tubular cells, whose
expression would be regulated by androgens.
Gender-dependent expression of the transporter has been
reported for the sodium taurocholate transporting polypeptide
[25], and oatp [21]. Lu et al. [21] reported that renal oatp
mRNA expression was under strong control of testosterone
and weaker regulation by estrogen. They speculated that this
regulation of renal oatp expression may be important in mod-
ulating the renal tubular secretion of 17L-D-glucuronide,
which is a major substrate of oatp. Although it is still unclear
why rOCT2, but not rOCT1, is sexually regulated by testos-
terone and partly by estradiol in the kidney, we speculate that
this transporter might play a physiological role in the meta-
bolic clearance of endogenous substances, which may be gen-
erated di¡erentially in males and females, for e¡ective removal
from the circulation to maintain hormone balance.
Recently, the human organic cation transporters hOCT1
and hOCT2 were cloned [26]. Northern blot analysis demon-
strated that hOCT1 is expressed primarily in the human liver,
while hOCT2 is expressed mainly in the human kidney. In situ
hybridization and immunohistochemical analyses indicated
expression of hOCT2 mainly in the distal tubule where the
transporter is localized at the luminal membrane [26]. There is
no information concerning gender di¡erences in expression of
hOCT2. Further studies are required to determine whether
there are gender di¡erences in hOCT2 expression and in cat-
ion transport mediated by hOCT2 in the human kidney.
In conclusion, we demonstrated that rOCT2 is responsible
for the gender di¡erences in renal organic cation transport
activity, possibly in the basolateral membranes of tubular epi-
thelial cells, and that the di¡erences in rOCT2 expression are
regulated by the overall balance of testosterone and estradiol.
These ¢ndings suggest that rOCT2 may play physiological
and pharmacological roles in renal clearance of endogenous
and exogenous organic cations from the blood.
Acknowledgements: This work was supported in part by a Grant-in-
Aid for Scienti¢c Research (B) from the Ministry of Education, Sci-
ence, Sports, and Culture of Japan, and by the Smoking Research
Foundation, and by a Grant-in-Aid from Uehara Memorial Founda-
tion.
References
[1] Pritchard, J.B. and Miller, D.S. (1993) Physiol. Rev. 73, 765^796.
[2] Ullrich, K.J. (1994) Biochim. Biophys. Acta 1197, 45^62.
[3] Inui, K. and Okuda, M. (1998) Clin. Exp. Nephrol. 2, 100^108.
[4] Holohan, P.D. and Ross, C.R. (1981) J. Pharmacol. Exp. Ther.
216, 294^298.
[5] Takano, M., Inui, K., Okano, T., Saito, H. and Hori, R. (1984)
Biochim. Biophys. Acta 773, 113^124.
[6] Hsyu, P.-H. and Giacomini, K.M. (1987) J. Biol. Chem. 262,
3964^3968.
[7] Wright, S.H. and Wunz, T.M. (1987) Am. J. Physiol. 253,
F1040^F1050.
[8] Sokol, P.P. and Mckinney, T.D. (1990) Am. J. Physiol. 258,
F1599^F1607.
[9] Inui, K., Saito, H. and Hori, R. (1985) Biochem. J. 227, 199^203.
[10] Saito, H., Yamamoto, M., Inui, K. and Hori, R. (1992) Am. J.
Physiol. 262, C59^C66.
[11] Koepsell, H., Gorboulev, V. and Arndt, P. (1998) J. Membr.
Biol. 167, 103^117.
[12] Gru«ndemann, D., Gorboulev, V., Gambaryan, S., Veyhl, M. and
Koepsell, H. (1994) Nature 372, 549^552.
[13] Okuda, M., Saito, H., Urakami, Y., Takano, M. and Inui, K.
(1996) Biochem. Biophys. Res. Commun. 224, 500^508.
[14] Okuda, M., Urakami, Y., Saito, H. and Inui, K. (1999) Biochim.
Biophys. Acta 1417, 224^231.
[15] Busch, A.E., Quester, S., Ulzheimer, J.C., Waldegger, S., Gor-
boulev, V., Arndt, P., Lang, F. and Koepsell, H. (1996) J. Biol.
Chem. 271, 32599^32604.
[16] Urakami, Y., Okuda, M., Masuda, S., Saito, H. and Inui, K.
(1998) J. Pharmacol. Exp. Ther. 287, 800^805.
[17] Busch, A.E., Quester, S., Ulzheimer, J.C., Gorboulev, V.,
Akhoundov, A., Waldegger, S., Lang, F. and Koepsell, H.
(1996) FEBS Lett. 395, 153^156.
[18] Martel, F., Vetter, T., Russ, H., Gruu«ndemann, D., Azevedo, I.,
Koepsell, H. and Scho«mig, E. (1996) Naunyn-Schmiedeberg’s
Arch. Pharmacol. 354, 320^326.
[19] Bowman, H.M. and Hook, J.B. (1972) Proc. Soc. Exp. Biol.
Med. 141, 258^262.
[20] Urakami, Y., Nakamura, N., Takahashi, K., Okuda, M., Saito,
H., Hashimoto, Y. and Inui, K. (1999) FEBS Lett. 461, 339^342.
[21] Lu, R., Kanai, N., Bao, Y., Wolko¡, A.W. and Schuster, V.L.
(1996) Am. J. Physiol. 270, F332^F337.
[22] Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter,
W.J. (1979) Biochemistry 18, 5294^5299.
[23] Ogihara, H., Saito, H., Shin, B.-C., Terada, T., Takenoshita, S.,
Nagamachi, Y., Inui, K. and Takata, K. (1996) Biochem. Bio-
phys. Res. Commun. 220, 848^852.
[24] Hori, R., Ishikawa, Y., Takano, M., Okano, T., Kitazawa, S.
and Inui, K. (1982) Biochem. Pharmacol. 31, 2267^2272.
[25] Simon, F.R., Fortune, J., Iwahashi, M., Bowman, S., Wolko¡,
A. and Sutherland, E. (1999) Am. J. Physiol. 276, G556^G565.
[26] Gorboulev, V., Ulzheimer, J.C., Akhoundova, A., Ulzheimer-
Teuber, I., Karbach, U., Quester, S., Baumann, C., Lang, F.,
Busch, A.E. and Koepsell, H. (1997) DNA Cell Biol. 16, 871^
881.
FEBS 23658 8-5-00
Y. Urakami et al./FEBS Letters 473 (2000) 173^176176
